Skip to content

Prediction Model of Occult Omental Metastasis in Patients With Gastric Cancer

A Nomogram for Predicting Occult Omental Metastasis in Patients With Gastric Cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06405009
Enrollment
450
Registered
2024-05-08
Start date
2024-04-22
Completion date
2024-06-30
Last updated
2024-05-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Cancer, Omental Metastasis

Brief summary

A complete omentectomy is typically recommended during radical total gastrectomy for gastric cancer, though its impact on survival remains unclear. This study aimed to assess the frequency and risk factors of metastases in the greater omentum in gastric cancer patients undergoing gastrectomy. It will involve a single prospective cohort of consecutive patients who underwent total gastrectomy with complete en bloc omentectomy and modified D2 lymphadenectomy. Post-surgery, the omentum will dissect from the gastrectomy specimen beyond the gastroepiploic vessels and examine separately for pathological assessment. The primary outcome will focus on the detection of omental metastases.

Interventions

OTHERWithout any intervention, we only divided gastric cancer patients into two groups based on postoperative pathology, and analyzed their basic characteristics and risk factors

Without any intervention, we only divided gastric cancer patients into two groups based on postoperative pathology, and analyzed their basic characteristics and risk factors

Sponsors

Northern Jiangsu People's Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. pathological confirmation of gastric cancer 2. eligibility for surgical intervention 3. undergoing first rectal cancer surgery 4. acquisition of written informed consent from patients and their families 5. no history of hypertrophic scar or allergic predispositions

Exclusion criteria

1. absence of postoperative pathology of the omentum 2. diagnosis of multiple primary malignancies 3. intraoperative discovery of widespread implant metastases within the abdominal cavity 4. severe comorbidities

Design outcomes

Primary

MeasureTime frameDescription
patients with omental metastasesup to 2 weeks after gastric cancer surgeryAfter the operation, the postoperative pathological examination of the patient indicated the presence of omental metastases
patients without omental metastasesup to 2 weeks after gastric cancer surgeryAfter surgery, pathological examination confirmed no omental metastases

Countries

China

Contacts

Primary ContactYifan Cheng
cyfchengyifan528@sina.com8615267258283

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026